Sublingual Buprenorphine for High-Risk Chronic Pain Patients

Drs. Wanhong Zheng & Patrick Marshalek from the West Virginia University High Risk Pain Clinic present their work and findings as published in their article “Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients”, J Clin Med. 2021 Mar: 10(5):973.

June 2023

You May Also Like

Related lectures

Behavioral Economics

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

Preparing for Dementia

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

Palliative Care at the End of the Hall

We are looking forward to resuming the HAPC Virtual Grand Rounds series and hoping this semester is the best one yet! Check out the upcoming....

Discover more from

Subscribe now to keep reading and get access to the full archive.

Continue reading